Randomized clinical trial to assess the efficacy of short course intermittent regimens for the treatment of HIV-associated tuberculosis
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ethambutol; Isoniazid; Pyrazinamide; Rifampicin
- Indications Tuberculosis
- Focus Therapeutic Use
- 03 Dec 2009 Primary endpoint 'Clinical cure rate' has not been met.
- 03 Dec 2009 Primary endpoint 'Bacteriological relapse rate' has been met.
- 11 Jun 2008 Biomarkers information updated